GOLM1 suppresses autophagy-mediated anti-tumor immunity in hepatocellular carcinoma

Signal Transduct Target Ther. 2021 Sep 17;6(1):335. doi: 10.1038/s41392-021-00673-6.

Tianqi Sui^#^{1

2}, Xiaoyang Wang^#^{2

3}, Lili Li^#^{1

2}, Junxiao Liu^{1

2}, Nan Qiao^{1

2}, Lihua Duan⁴, Minxin Shi⁵, Jianfei Huang⁶, Heng Yang^{7

8}, Genhong Cheng⁹

¹ Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
² Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China.
³ Heze Vocational College, Heze, Shandong, China.
⁴ Department of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China.
⁵ Affiliated Tumour Hospital of Nantong University, Nantong Tumour Hospital, Nantong, Jiangsu, China.
⁶ Department of Clinical Biobank, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
⁷ Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. yhmyt@hotmail.com.
⁸ Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China. yhmyt@hotmail.com.
⁹ Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA. gcheng@mednet.ucla.edu.

^# Contributed equally.

No abstract available

Publication types